Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-target nano-therapy against cerebral ischemia/reperfusion injury <i>via</i> combinatorial inhibition of neuroinflammation and pyroptosis.

Journal of materials chemistry. B·2026
Same author

Comparison of Single Fiber Transperineal Laser Ablation and Radiofrequency Ablation in the Treatment of Benign Prostatic Hyperplasia.

Cardiovascular and interventional radiology·2026
Same author

Superparamagnetic iron oxide nanoparticle-driven 3-aroyl-1,4-diarylpyrrole nanocomposites (ARDAP@SPION-PEI) mediate renal cancer cell PANoptosis by regulating chromatin accessibility.

Molecular biomedicine·2026
Same author

Bacterial Identification through Detection of Their Specific Proteins via MALDI-TOF MS.

Journal of agricultural and food chemistry·2026
Same author

Cu-Mn Bimetallic Mesoporous Silica Nanosonosensitizers Enable Oxeiptosis-Mediated Sonodynamic Therapy for Ultra-Minimally Invasive Treatment of Benign Prostatic Hyperplasia.

ACS applied materials & interfaces·2025
Same author

Evaluating the Therapeutic Role of Lymph Node Dissection in Variant Subtype Bladder Cancer.

Cancers·2025

Related Experiment Video

Updated: Oct 7, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.6K

Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability

Qiang Liu1,2, Hongliang Shen1,3, Andrew Naguib1

  • 1Department of Urology, Yale University School of Medicine, New Haven, CT, USA.

Molecular Biomedicine
|January 10, 2022
PubMed
Summary

Targeting Claudins 3 and 4 (Cldn3/Cldn4) in prostate cancer cells significantly reduced their growth, viability, and migration. This suggests Cldn3/Cldn4 as potential therapeutic targets for advanced prostate cancer.

Keywords:
Cancer cell migrationCancer cell survivalCell receptorsClaudin-3 (Cldn3)Claudin-4 (Cldn4)Molecular targeted therapy

More Related Videos

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

12.5K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.3K

Related Experiment Videos

Last Updated: Oct 7, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.6K
Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

12.5K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Prostate cancer is a prevalent invasive malignancy in the US.
  • Claudins (Cldns), transmembrane proteins, are implicated in cancer progression and are elevated in various cancers, including prostate cancer.
  • Elevated Cldn3 and Cldn4 levels are observed in aggressive and metastatic prostate cancer specimens.

Purpose of the Study:

  • To investigate the functional role of Claudins 3 and 4 (Cldn3/Cldn4) in prostate cancer.
  • To determine the effects of targeting Cldn3/Cldn4 expression on prostate cancer cell growth, viability, and migration.

Main Methods:

  • Human prostate cancer cell lines (PC3 and LNCaP) were utilized.
  • Cells were transfected with small interfering RNAs (siRNAs) specific for Cldn3 or Cldn4.
  • Protein levels, cell growth, viability, migration, and colony formation were assessed post-transfection.

Main Results:

  • siRNA treatment led to an >85% decrease in Cldn3/Cldn4 protein levels.
  • Prostate cancer cell growth decreased by 30-40%, and cell viability reduced by 60-65%.
  • Cell migration was reduced, and colony formation decreased by 60-75% in siRNA-treated cells compared to controls.

Conclusions:

  • Knockdown of Cldn3/Cldn4 significantly inhibits prostate cancer cell growth, survival, and migration.
  • Claudins 3 and 4 represent promising molecular targets for therapeutic intervention in advanced prostate cancer.
  • These findings highlight the potential of targeting Cldn3/Cldn4 for future prostate cancer therapies.